Sign In
Buy ACCD
$7.02
+0 (+0%)
At Close: Jul 07, 2025
Accolade, Inc. (ACCD) Q1 2024 Earnings Call Transcript
07:23pm, Thursday, 29'th Jun 2023
Accolade, Inc. (NASDAQ:ACCD ) Q1 2024 Earnings Conference Call June 29, 2023 4:30 PM ET Company Participants Todd Friedman - SVP, IR Rajeev Singh - CEO Steve Barnes - CFO Shantanu Nundy - Chief Health
Accolade (ACCD) Reports Q1 Loss, Tops Revenue Estimates
06:54pm, Thursday, 29'th Jun 2023
Accolade (ACCD) came out with a quarterly loss of $0.52 per share versus the Zacks Consensus Estimate of a loss of $0.64. This compares to loss of $0.40 per share a year ago.
Accolade to Announce Fiscal First Quarter 2024 Financial Results
08:00am, Tuesday, 13'th Jun 2023
SEATTLE, June 13, 2023 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), a healthcare provider that serves millions of members, today announced that it will release fiscal first quarter 2024 financi
Accolade To Present at Stifel 2023 Cross Sector Insight Conference
11:04am, Thursday, 01'st Jun 2023
SEATTLE, June 01, 2023 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), a healthcare provider that serves millions of members, today announced that it will be presenting at the Stifel 2023 Cross Se
Accolade: FY25 And Long-Term Targets Inspire Confidence
10:24am, Saturday, 27'th May 2023
ACCD has experienced high demand, with revenue increasing by 5.6% in 4Q23 and a 33% increase in ARR bookings. During the analyst day, ACCD upgraded its FY25 margin target and expressed confidence in r
Accolade Inc CFO Stephen Barnes Sells 631 Shares: An Insider Sell Analysis
10:08pm, Thursday, 25'th May 2023
On May 23, 2023, Stephen Barnes, the Chief Financial Officer (CFO) of Accolade Inc ( ACCD , Financial), sold 631 shares of the company. This article will provide an overview of Stephen Barnes, Accolad
Accolade Inc CEO Rajeev Singh Sells 1,553 Shares: An Insider Sell Analysis
10:08pm, Thursday, 25'th May 2023
On May 23, 2023, Rajeev Singh, the CEO of Accolade Inc ( ACCD , Financial), sold 1,553 shares of the company. This article will provide an analysis of this insider sell, the relationship between insid
Accolade Inc CEO Rajeev Singh Sells 1,456 Shares
10:07pm, Thursday, 25'th May 2023
On May 24, 2023, Rajeev Singh, the CEO of Accolade Inc ( ACCD , Financial), sold 1,456 shares of the company's stock. This move comes amidst a year of both buying and selling activity for Singh, who h
Accolade (ACCD) Upgraded to Buy: What Does It Mean for the Stock?
01:13pm, Wednesday, 24'th May 2023
Accolade (ACCD) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Top 5 Health Care Stocks That Could Lead To Your Biggest Gains In May - Bio-Rad Laboratories (NYSE:BIO), Accolade (NASDAQ:ACCD)
08:00am, Thursday, 11'th May 2023
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
Accolade, Inc. (ACCD) Q4 2023 Earnings Call Transcript
11:11pm, Thursday, 27'th Apr 2023
Accolade, Inc. (ACCD) Q4 2023 Earnings Call Transcript.
Accolade (ACCD) Reports Q4 Loss, Misses Revenue Estimates
07:01pm, Thursday, 27'th Apr 2023
Accolade (ACCD) came out with a quarterly loss of $0.42 per share versus the Zacks Consensus Estimate of a loss of $0.43. This compares to loss of $0.27 per share a year ago.
Accolade to Webcast Analyst Day on May 8, 2023
04:05pm, Monday, 24'th Apr 2023
SEATTLE, April 24, 2023 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), a healthcare provider that serves millions of members, today announced that it will host an Analyst Day at the Wynn Las Vega
Accolade to Announce Fiscal Fourth Quarter 2023 Financial Results
08:00am, Tuesday, 11'th Apr 2023
SEATTLE, April 11, 2023 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), a healthcare provider that serves millions of members, today announced that it will release fiscal fourth quarter 2023 finan
Healthcare company Accolade lays off workers and closes offices
08:32pm, Monday, 06'th Mar 2023
Seattle and Philadelphia area-based primary healthcare company Accolade is cutting its workforce and closing or reducing some facilities, according to a recent regulatory filing.
